Strs Ohio lowered its position in HCP Inc. (NYSE:HCP) by 2.8% during the second quarter, Holdings Channel reports. The firm owned 730,481 shares of the real estate investment trust’s stock after selling 21,011 shares during the period. Strs Ohio’s holdings in HCP were worth $25,844,000 as of its most recent filing with the SEC.
Other hedge funds have also bought and sold shares of the company. Checchi Capital Advisers LLC increased its stake in HCP by 3.9% in the second quarter. Checchi Capital Advisers LLC now owns 5,288 shares of the real estate investment trust’s stock worth $187,000 after buying an additional 200 shares during the period. First National Bank of Mount Dora Trust Investment Services increased its stake in HCP by 0.6% in the second quarter. First National Bank of Mount Dora Trust Investment Services now owns 53,188 shares of the real estate investment trust’s stock worth $1,882,000 after buying an additional 300 shares during the period. Charter Trust Co. increased its stake in HCP by 1.2% in the second quarter. Charter Trust Co. now owns 25,290 shares of the real estate investment trust’s stock worth $895,000 after buying an additional 310 shares during the period. Glenmede Trust Co. NA increased its stake in HCP by 1.0% in the first quarter. Glenmede Trust Co. NA now owns 43,235 shares of the real estate investment trust’s stock worth $1,407,000 after buying an additional 428 shares during the period. Finally, Capstone Asset Management Co. increased its stake in HCP by 1.3% in the second quarter. Capstone Asset Management Co. now owns 36,490 shares of the real estate investment trust’s stock worth $1,291,000 after buying an additional 475 shares during the period. 90.96% of the stock is owned by hedge funds and other institutional investors.
Shares of HCP Inc. (NYSE:HCP) traded down 2.12% during trading on Tuesday, reaching $38.76. The company had a trading volume of 3,713,458 shares. HCP Inc. has a 12 month low of $25.11 and a 12 month high of $40.43. The firm’s market capitalization is $18.12 billion. The stock has a 50 day moving average price of $38.88 and a 200 day moving average price of $35.84.
HCP (NYSE:HCP) last issued its quarterly earnings data on Tuesday, August 9th. The real estate investment trust reported $0.74 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.70 by $0.04. HCP had a negative return on equity of 0.67% and a negative net margin of 2.52%. The business had revenue of $662.20 million for the quarter, compared to the consensus estimate of $631.25 million. During the same period last year, the business earned $0.79 EPS. The firm’s revenue was up 9.0% compared to the same quarter last year. On average, equities research analysts forecast that HCP Inc. will post $2.83 EPS for the current year.
Several analysts have issued reports on the stock. Argus reaffirmed a “hold” rating on shares of HCP in a research report on Sunday, September 18th. Mizuho increased their price objective on shares of HCP from $32.00 to $37.00 and gave the company a “neutral” rating in a research report on Wednesday, August 10th. Raymond James Financial Inc. assumed coverage on shares of HCP in a research report on Tuesday, July 26th. They issued an “underperform” rating for the company. BMO Capital Markets reaffirmed a “sell” rating on shares of HCP in a research report on Monday, June 20th. Finally, Barclays PLC downgraded shares of HCP from an “equal weight” rating to an “underweight” rating and lowered their price objective for the company from $40.00 to $37.00 in a research report on Wednesday, June 1st. Seven investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average price target of $33.93.
In other HCP news, EVP Jonathan M. Bergschneider sold 7,651 shares of HCP stock in a transaction that occurred on Tuesday, August 23rd. The stock was sold at an average price of $39.78, for a total value of $304,356.78. Following the transaction, the executive vice president now directly owns 54,095 shares of the company’s stock, valued at approximately $2,151,899.10. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Darren A. Kowalske sold 2,250 shares of HCP stock in a transaction that occurred on Wednesday, August 31st. The stock was sold at an average price of $39.20, for a total value of $88,200.00. Following the completion of the transaction, the insider now directly owns 9,793 shares in the company, valued at $383,885.60. The disclosure for this sale can be found here. 0.22% of the stock is owned by company insiders.
HCP, Inc (HCP) is a self-administered real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital.
Want to see what other hedge funds are holding HCP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCP Inc. (NYSE:HCP).
Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with MarketBeat.com's FREE daily email newsletter.